Kiara Banerjee’s Post

Embracing biosimilars is revolutionising healthcare! 💊   As pharmaceutical firms lean towards biosimilars for cost-efficiency and enhanced patient reach, the landscape of healthcare is rapidly changing. 💡 Discover firsthand insights from rheumatologists, nurses, and pharmacists managing this transition, and learn about the practical effects for healthcare professionals and patients in our Innovation and Insight piece, here👉 https://lnkd.in/e7raNzAy What are your thoughts on the shift towards biosimilars? Share your thoughts in the comments! 💬 #Biosimilars #Healthcare #HealthcareInnovation #Pharmaceuticals #PatientCare #PatientSupport #PatientCentricity #PatientExperience #NHS

WHEN PATIENTS pick up their prescriptions, they often don't have questions. However, it's during the course of their treatment that they may have concerns or inquiries. The key to achieving the best outcomes in treatments lies in healthcare professionals who listen attentively to their patients. Unfortunately, some healthcare providers may overlook the valuable insights shared by patients and their caregivers. Patient feedback is a valuable source of information that can assist pharmaceutical companies in early reformulation and mitigating potential risks associated with side effects. ZIPPYAR offers a platform for patient engagement through video instructions for prescriptions. This allows patients to provide feedback on their treatments and ask questions, fostering better communication and understanding. #pharmaceutical #engagement

Are you looking to navigate the complexities of European market access and reimbursement in the pharmaceutical industry? Learn how we can support your needs.

Pharmacy’s Role in Treating Rare Disease: Connecting Patients, Providers, Payers, and Pharma: Pharmacy's position at the intersection of the care team gives it a unique ability to connect providers, payers, and pharmaceutical manufacturers, and support patients to maximize their health outcomes. #finance #pharmacy #lifesciences

Excited to share our latest project leveraging data analytics to forecast trends in medication prescriptions and adherence! 📊💊 We aimed to anticipate shifts in medication usage, helping healthcare providers and pharmaceutical companies adapt effectively. Here's a snapshot: 🎯 **Objective**: Predicting medication prescription trends and adherence levels, identifying potential increases and decreases. 📊 **Data Sets**: - Medicaid & CHIP Open Data State Drug Utilization via Data.Medicaid.Gov - Drug Reviews via Kaggle.com - Prescription Drug Use in HRRs and HSAs via Kaggle.com 🔍 **Analysis**: - **Linear Regression**: Projecting prescription volumes for each drug in 2030. - **Sentiment Analysis**: Assessing positive and negative responses to drugs to gauge adherence likelihood. Our findings offer actionable insights into future medication trends, empowering stakeholders to make informed decisions in healthcare delivery and pharmaceutical strategy. Exciting times ahead for precision healthcare! 🚀 #DataAnalytics #HealthcareTrends #PredictiveAnalytics

Are you looking to navigate the complexities of European market access and reimbursement in the pharmaceutical industry? Learn how we can support your needs.

Who is ready to discuss the trends in Patient Services for 2024? CareMetx surveyed providers and manufacturers to understand where we have made strides, and where there is still a ways to go. Increasing patient satisfaction emerged as the most important business objective for the pharmaceutical manufacturers and HCPs surveyed. Providing better support across the patient journey ranked close behind. Check out the full report here:  Elizabeth Kanter Eliza Silvester Elizabeth Pinto Tanya Carro https://lnkd.in/gNQN3BrS

I recently hosted a webinar together with Mark Tolboom to discuss the increasing need for post-launch evidence generation in the pharmaceutical industry. We explored the power of value-based partnerships and real time outcomes measurement in addressing this challenge. By collaborating with healthcare providers and collecting real-time, real-world outcomes, we can generate the evidence needed to show the added value of new medicines. If you didn’t have a chance to join us live, don’t worry here you can access the on-demand recording of the webinar: https://lnkd.in/d-SEGhdW Join us in transforming healthcare delivery and improving patient access through value-based healthcare. #VBHC #evidencegeneration #partnerships #outcomesmeasurement

😊 Patient support programs (PSPs) are strategic assets for pharmaceutical companies, significantly enhancing patient adherence and outcomes 📈, providing invaluable data 📊, and improving market differentiation 📣. By fostering long-term loyalty and trust 🤝, these programs also bolster regulatory compliance ✔️, manage costs 💰, and contribute to the overall success and sustainability of pharmaceutical companies 🌟. Investing in PSPs ensures that medications deliver maximum benefits to patients, healthcare providers, and the broader healthcare system 🏥. Through these programs, pharmaceutical companies demonstrate a commitment to comprehensive patient care 💖, driving better health outcomes and reinforcing their market position 📌. For more information, please connect at ankit.pandya@watchyourhealth.com #PatientSupportPrograms #PharmaInnovation #HealthcareExcellence #PatientAdherence #PharmaSuccess #BetterHealthOutcomes #PatientCare #PharmaStrategy #HealthcareInnovation #PatientEngagement #watchyourhealth

The pharmaceutical industry has many customers, including healthcare professionals and payers, but the ultimate customers are always patients. How can pharmaceutical companies become truly patient-centric? It is critical to embed patient centricity in day-to-day activities by adopting a structured, rigorous approach that engages employees across the value chain. To learn why patient centricity matters, critical factors for success and how to overcome common hurdles, download our whitepaper now: https://lnkd.in/eDdjVt6g #PatientCentricity #Pharma #Pharmaceuticals #PharmaceuticalStrategy #Strategy #Consulting